160 related articles for article (PubMed ID: 10942113)
21. Genetic analysis of autoimmune regulator haplotypes in alopecia areata.
Wengraf DA; McDonagh AJ; Lovewell TR; Vasilopoulos Y; Macdonald-Hull SP; Cork MJ; Messenger AG; Tazi-Ahnini R
Tissue Antigens; 2008 Mar; 71(3):206-12. PubMed ID: 18194361
[TBL] [Abstract][Full Text] [Related]
22. Single nucleotide polymorphisms in the promoter regions of Foxp3 and ICOSLG genes are associated with Alopecia areata.
Conteduca G; Rossi A; Megiorni F; Parodi A; Ferrera F; Tardito S; Battaglia F; Kalli F; Negrini S; Pizzuti A; Rizza E; Indiveri F; Fenoglio D; Filaci G
Clin Exp Med; 2014 Feb; 14(1):91-7. PubMed ID: 23196741
[TBL] [Abstract][Full Text] [Related]
23. Functional polymorphisms in cell death pathway genes FAS and FAS ligand and risk of alopecia areata.
Kalkan G; Ateş O; Karakuş N; Sezer S
Arch Dermatol Res; 2013 Dec; 305(10):909-15. PubMed ID: 23591741
[TBL] [Abstract][Full Text] [Related]
24. Genetic variant association of PTPN22, CTLA4, IL2RA, as well as HLA frequencies in susceptibility to alopecia areata.
Moravvej H; Tabatabaei-Panah PS; Abgoon R; Khaksar L; Sokhandan M; Tarshaei S; Ghaderian SMH; Ludwig RJ; Akbarzadeh R
Immunol Invest; 2018 Oct; 47(7):666-679. PubMed ID: 29979892
[TBL] [Abstract][Full Text] [Related]
25. Genomewide analysis of copy number variants in alopecia areata in a Central European cohort reveals association with MCHR2.
Fischer J; Degenhardt F; Hofmann A; Redler S; Basmanav FB; Heilmann-Heimbach S; Hanneken S; Giehl KA; Wolff H; Moebus S; Kruse R; Lutz G; Blaumeiser B; Böhm M; Garcia Bartels N; Blume-Peytavi U; Petukhova L; Christiano AM; Nöthen MM; Betz RC
Exp Dermatol; 2017 Jun; 26(6):536-541. PubMed ID: 27306922
[TBL] [Abstract][Full Text] [Related]
26. Genetic evidence for the involvement of NOTCH4 in rheumatoid arthritis and alopecia areata.
AlFadhli S; Nanda A
Immunol Lett; 2013 Feb; 150(1-2):130-3. PubMed ID: 23318300
[TBL] [Abstract][Full Text] [Related]
27. Vitamin D receptor gene polymorphisms are not associated with alopecia areata.
Akar A; Orkunoglu FE; Tunca M; Taştan HB; Kurumlu Z
Int J Dermatol; 2007 Sep; 46(9):927-9. PubMed ID: 17822494
[TBL] [Abstract][Full Text] [Related]
28. Epidemiology and genetics of alopecia areata.
McDonagh AJ; Tazi-Ahnini R
Clin Exp Dermatol; 2002 Jul; 27(5):405-9. PubMed ID: 12190641
[TBL] [Abstract][Full Text] [Related]
29. Polymorphisms in the promoter regions of the CXCL1 and CXCL2 genes contribute to increased risk of alopecia areata in the Korean population.
Kim SK; Chung JH; Park HJ; Kang SW; Lim DJ; Byun SH; Baek DG; Ko HY; Lew BL; Baik HH; Sim WY
Genet Mol Res; 2015 Aug; 14(3):9667-74. PubMed ID: 26345899
[TBL] [Abstract][Full Text] [Related]
30. Epidemiologic and genetic characteristics of alopecia areata (part 2).
Alzolibani AA; Zari S; Ahmed AA
Acta Dermatovenerol Alp Pannonica Adriat; 2012; 21(1):15-9. PubMed ID: 22584901
[TBL] [Abstract][Full Text] [Related]
31. Association between IL16 gene polymorphisms and susceptibility to alopecia areata in the Korean population.
Lew BL; Chung JH; Sim WY
Int J Dermatol; 2014 Mar; 53(3):319-22. PubMed ID: 24320753
[TBL] [Abstract][Full Text] [Related]
32. Analysis of the monocyte chemoattractant protein 1 -2518 promoter polymorphism in Korean patients with alopecia areata.
Hong SB; Jin SY; Park HJ; Jung JH; Sim WY
J Korean Med Sci; 2006 Feb; 21(1):90-4. PubMed ID: 16479072
[TBL] [Abstract][Full Text] [Related]
33. Methylenetetrahydrofolate reductase C677T mutation in patients with alopecia areata in Turkish population.
Kalkan G; Yigit S; Karakuş N; Ateş O; Bozkurt N; Ozdemir A; Pancar GŞ
Gene; 2013 Nov; 530(1):109-12. PubMed ID: 23954881
[TBL] [Abstract][Full Text] [Related]
34. The TRAF1/C5 locus confers risk for familial and severe alopecia areata.
Redler S; Brockschmidt FF; Forstbauer L; Giehl KA; Herold C; Eigelshoven S; Hanneken S; De Weert J; Lutz G; Wolff H; Kruse R; Blaumeiser B; Böhm M; Becker T; Nöthen MM; Betz RC
Br J Dermatol; 2010 Apr; 162(4):866-9. PubMed ID: 20030635
[TBL] [Abstract][Full Text] [Related]
35. TNF-α -308G/A gene polymorphism in bullous pemphigoid and alopecia areata.
Moravvej H; Tabatabaei-Panah PS; Ebrahimi E; Esmaeili N; Ghaderian SMH; Ludwig RJ; Akbarzadeh R
Hum Antibodies; 2018; 26(4):201-207. PubMed ID: 29843231
[TBL] [Abstract][Full Text] [Related]
36. The human FE65 gene: genomic structure and an intronic biallelic polymorphism associated with sporadic dementia of the Alzheimer type.
Hu Q; Kukull WA; Bressler SL; Gray MD; Cam JA; Larson EB; Martin GM; Deeb SS
Hum Genet; 1998 Sep; 103(3):295-303. PubMed ID: 9799084
[TBL] [Abstract][Full Text] [Related]
37. PTPN22 profile indicates a novel risk group in Alopecia areata.
Bhanusali DG; Sachdev A; Olson MA; Gerlach JA; Sinha AA
Hum Immunol; 2014 Jan; 75(1):81-7. PubMed ID: 24055692
[TBL] [Abstract][Full Text] [Related]
38. Major histocompatibility complex class I chain-related gene A polymorphisms and extended haplotypes are associated with familial alopecia areata.
Barahmani N; de Andrade M; Slusser JP; Zhang Q; Duvic M
J Invest Dermatol; 2006 Jan; 126(1):74-8. PubMed ID: 16417220
[TBL] [Abstract][Full Text] [Related]
39. Influence of MX1 promoter rs2071430 G/T polymorphism on susceptibility to systemic lupus erythematosus.
AlFadhli S; Al-Mutairi M; Al Tameemi B; Nizam R
Clin Rheumatol; 2016 Mar; 35(3):623-9. PubMed ID: 26815367
[TBL] [Abstract][Full Text] [Related]
40. Association analysis of IL1A and IL1B variants in alopecia areata.
Tazi-Ahnini R; McDonagh AJ; Cox A; Messenger AG; Britton JE; Ward SJ; Båvik CO; Duff GW; Cork MJ
Heredity (Edinb); 2001 Aug; 87(Pt 2):215-9. PubMed ID: 11703512
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
